NC
Nexthera Capital Portfolio holdings
AUM
$120M
1-Year Return
20.18%
This Quarter Return
+14.33%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$147M
AUM Growth
-$6.02M
(-3.9%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-10.51%
Top 10 Holdings %
Top 10 Hldgs %
81.82%
Holding
53
New
13
Increased
4
Reduced
7
Closed
18
Top Buys
| 1 |
Pfizer
PFE
|
$16M |
| 2 |
GSK
GSK
|
$13.3M |
| 3 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$7.65M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$7.17M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$5.32M |
Top Sells
| 1 |
Novartis
NVS
|
$14.4M |
| 2 |
AstraZeneca
AZN
|
$8.2M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$8.09M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$6.18M |
| 5 |
Neurocrine Biosciences
NBIX
|
$4.64M |
Sector Composition
| 1 | Healthcare | 93.44% |